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We considered whether there are discrete windows of vulnerability in the development of cancer
and which time periods may be of the greatest importance. Cancer was considered broadly,
including cancers in childhood as well as adult cancers that may have an in utero or childhood origin.
We concluded that there was evidence from animal and epidemiologic studies for causal
relationships for preconceptional, in utero, and childhood exposures and cancer occurrence in
children and adults. However, the evidence is incomplete and all relevant critical windows may not
have been identified. The comprehensive evaluation of the relative importance of specific time
windows of exposure is limited. Improvements in the design of epidemiologic studies and
additional animal studies of mechanisms are warranted. Key words: adult, child, environmental,
neoplasm. - Environ Health Perspect 108(suppl 3):595-597 (2000).
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Anderson et al. (1) raised a number of
observations and issues on the human epi-
demiologic and animal evidence for win-
dows ofvulnerability in the development of
cancer. This report summarizes these obser-
vations and issues considered by the cancer
breakout group. We considered whether
there are discrete windows ofvulnerability
in the development of cancer and, if so,
which time periods are of the greatest
importance. We discussed cancer in a broad
context, with consideration of cancers in
childhood as well as adult cancers that may
have an in utero or childhood origin.
Priority Questions
The animal and human epidemiologic
findings summarized by Anderson et al. (1)
provide evidence for the association between
exposures in specific windows and increased
risks of cancer in childhood and adulthood.
For example, some animal experiments
using chemicals or radiation showed that
exposure of the male animal before mating
with an untreated female results in an excess
ofoffspring with cancer (1). This finding
has a number ofimplications that have gen-
erally not been fully appreciated. First, it
shows that exposure to toxicants during the
preconception period can result in cancer in
the next generation. Second, the experi-
ments indicate that paternal exposures can
increase cancer risk in offspring (1). The
area of male-mediated developmental
toxicity remains controversial given the
inconsistent evidence for association in epi-
demiologic studies of childhood cancer
(1,2). Nonetheless, the relatively consistent
animal evidence suggests that studies of
adult cancer should consider the role of
paternal exposures as well as maternal and in
utero influences.
The evidence for the in utero period as a
critical window is based in large part on the
compelling results from the study ofdiethyl-
stilbestrol and vaginal adenocarcinoma in
young women (3). A number ofearly studies
reported an association between ionizing
radiation and leukemia in childhood (4).
Finally, results from the study ofJapanese
atomic bomb survivors find an increased risk
of breast and other cancers in adulthood
after childhood exposure to high-dose
radiation (5).
Thus, there appears to be strong evi-
dence from animal and epidemiologic
studies for causal relationships including
exposure preconceptionally, in utero, and
during childhood and cancer occurrence in
children and adults. Nevertheless, Table 1
shows that even for the best-studied expo-
sure (ionizing radiation), the evidence is
incomplete for certain windows ofexposure,
in particular prenatal exposures and adult
cancer. Therefore, all relevant critical win-
dows may not have been delineated.
Further, the comprehensive evaluation of
the relative importance ofspecific time win-
dows of exposure is limited by the lack of
empirical evidence. The complexity of car-
cinogenesis and the lack of a general model
will seriously inhibit a default prediction of
critical window effects and direct incorpora-
tion into risk assessment models.
Issues
A major limitation in the available empirical
evidence is the lack of a holistic pathogenetic
model that encompasses childhood and adult
cancers. Without such a unifying model, the
theoretical basis offuture epidemiologic and
animal studies is missing. This is in contrast
to other health outcomes such as birth
defects, where one can use a well-described
model ofembryogenesis to make predictions
about the likely effects of teratogens on spe-
cific structures at specific time periods. Of
course, there are some general models ofmul-
tistep carcinogenesis incorporating initiation
and progression parameters that allow some
predictions as to the potential early or late
effects of agents. Experimental studies showed
that there are a number ofsusceptibility fac-
tors at different stages of transplacental and
neonatal carcinogenesis (e.g., target cells at
risk, DNA repair capacity, metabolic detoxifi-
cation, etc.) that are not really incorporated
into the general multistep models in our cur-
rent understanding ofearly and late effects of
environmental exposures (1).
One model that has proven useful for
considering childhood tumors is the two-
stage model described by Knudson et al. (6).
Knudson et al. (6) posited at least two
events; the first is either a germline mutation
(or other inactivating event) or somatic
mutation, and the second is at least one
somatic mutation. The authors used descrip-
tive epidemiologic and genetic data to
suggest that for several childhood cancers
(e.g., Wilms tumor, neuroblastoma, and
retinoblastoma), hereditary case diagnoses
(those cases with a positive family history or
those that inherited a de novo germline muta-
tion or other features) would be at a younger
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Table 1. Critical time windows and ionizing radiation.a
Childhood cancer Adult cancer
Time window Human Animal Human Animal
Preconception Paternal: limited/suggestive Paternal: noneb Sufficientfor lung, lymphoid, skin,
uterus
Suggestive for liver, ovary, mammary
Maternal: limited Maternal: noneb
In utero Maternal: abdominal X rays Limited/suggestive Limited Sufficient for lymphoid, lung, liver,
Sufficient for leukemia (limited kidney, nervous system, lymphoid,
relevance today) ovary, pituitary, skin, sarcoma,
uterus
Suggestive for mammarygland,
thyroid
Postnatal Sufficient (leukemia, thyroid, Suggestive forthymus High dose(Japanese atomic bomb) Sufficientfor lung, liver, kidney,
other) and myeloid leukemia and several cancer types lymphoid, uterus, Harderian gland
Therapeutic radiation and Suggestive for ovary, skin, nervous
several cancers system, mammarygland
Risk ofyoung onset breast cancer
increased with exposure
< 10 years old
aReferences to specific studies can be found in Anderson et al. (1). bAnimal experiments usually do not produce childhood tumors based on age orhistology.
age than for sporadic cases. This is because
cases with germline mutations would be
primed, with all cells ofthe offspring carry-
ing the initial mutation and only a second
somatic mutation would be required for
tumor development. In these cases, com-
pared with those requiring two somatic
mutations (sporadic), the time to event
would be shorter and would yield a younger
age at diagnosis. Later molecular studies of
tumor-suppressor genes lent support to the
basic framework of the Knudson et al. (6)
model. Thus, the model predicts that agents
which result in a mutation (or epigenetic
alteration) in the parental germline would
result in childhood cancer cases with a
younger age at diagnosis. This is most useful
for thinking about paternal exposures where
the expected mechanism or critical window
would be a germline mutation. Although the
possibility that fathers could bring home tox-
icants which could expose the pregnant
mother and fetus cannot be ruled out, this is
less likely than a direct effect on the male
germ cells. This model can then be used to
predict that paternal preconceptional expo-
sure, ifcausally associated, would result in
offspring with a younger age at diagnosis.
Maternal preconceptional exposures cannot
be ruled out, although they have not been as
well studied. Thus, although indirect, this
model provides some basis for considering a
critical window for childhood cancers.
Further, the Knudson et al. (6) model can be
used to develop and test hypotheses related
to adult cancers; exposures during the time
periods around conception and pregnancy
may provide the initial mutational event
that, combined with additional events later
in life, will increase the risk of cancer in
adulthood. Similarly, a person with a
germline alteration would be a greater risk of
adult cancer with the presence ofexposure-
induced somatic alterations postnatally.
Another issue is that animal models, with
some exceptions, do not permit direct anal-
ogy with childhood cancer. That is, in exper-
imental animal studies, preconceptional,
transplacental, and neonatal carcinogenesis is
not comparable to childhood cancer in
humans (1). There is not an analogous child-
hood in laboratory animals; therefore, most
studies relate to adult human tumors on the
basis of age of appearance and histology.
Nonetheless, animal studies will continue to
provide important data on the effects of
exposure during various stages before, dur-
ing, and after pregnancy. Further, these
studies are important for their ability to iden-
tify susceptibility factors, to establish toxico-
kinetic models, and to provide mechanistic
information (1).
Gaps in Knowledge
There are a number ofgaps in knowledge on
exposures in specific windows and increased
risk of cancer [reviewed by Anderson et al.
(1)]. Table 1 provides clear evidence for the
sparseness ofthe data on ionizing radiation.
In human studies there is a dire need for
higher quality epidemiologic data on a range
ofexposures within and across time periods.
These gaps exist because ofa variety oflimi-
tations frequently encountered in epidemio-
logic studies, such as study size, exposure
measurement, confounding, and other
biases. Exposure assessment is a serious chal-
lenge in two respects. First, most recent
studies for childhood cancer have been
multicenter case-control studies. Obtaining
valid exposure data from parents, often
through self-report, remains a major con-
cern. In adult cancer studies, obtaining
extensive exposure data for the subject's own
pregnancy and childhood or for their
parents' preconceptional period is presently
in most cases impossible. A basic problem
with most epidemiologic studies is the diffi-
culty in accounting for the interaction
among exposures within and across time
periods. Even for a single exposure, the abil-
ity to estimate meaningful effects ofan expo-
sure that occurs across multiple time periods
can be limited. Currently, there is a great
interest in the identification ofgenetic sus-
ceptibility factors in cancer and the role of
gene-environment interactions in the devel-
opment ofchildhood cancers. For example, a
recent study oftwins with acute lymphoblas-
tic leukemia used polymerase chain reaction
methods to detect a marker ofchromosomal
translocation and reported that this child-
hood leukemia is often initiated in utero but
requires additional postnatal events (7,8).
Epidemiologic studies are needed to evaluate
the role ofgene-environment interactions in
these events. In addition, there are few
studies of metabolic enzyme polymorphisms
and exposures in relation to the risk ofchild-
hood cancers (9). A number of phase I
enzymes (cytochrome P450s, for example)
involved in the activation ofa variety ofcar-
cinogens, medications, and other com-
pounds, as well as phase II enzymes (e.g.,
glutathione S-transferases) that play a role in
detoxication are possible candidates for
investigation (10). Polymorphisms ofgenes
involved in the DNA repair process are now
available for evaluation (11). In addition,
enzymes that metabolize nutrients, such as
5,10-methylenetetrahydrofolate reductase,
are also ofinterest (12). It is not clear what
the priority enzymes or receptors and related
substrates or ligands should be or the relative
contributions of paternal, maternal, or fetal
genotypes. The identification ofsusceptibility
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factors may strengthen previously moderate
or weak associations or reveal new associa-
tions with exposures.
There are further gaps in the experimen-
tal animal data: Additional mechanistic
information is needed. For example, studies
of male exposure to chromium showed an
increased incidence of cancer in offspring
(1). However, the mechanism underlying
these findings is not clear and an epigenetic
mechanism may be of interest. Additional
work on the molecular basis of epigenetic
phenomena (e.g., methylation and imprint-
ing) and the influence oftoxicants on altering
these events is warranted (13). The relation-
ship ofexperimental studies with human data
is not always direct; better linkage is required.
Finally, much of the animal data relate to
important exposures such as ionizing radia-
tion and other known strong mutagens.
However, there is a need to also study a
broader range ofexposures that may have a
different structure-function relationship.
Recommendations
The gaps in knowledge suggest a number of
recommendations for future research in this
area. Epidemiologic studies can be improved
in a number ofways. First, epidemiologists
should be more opportunistic in investigat-
ing uniquely exposed cohorts. Cohorts such
as those defined by occupation, medical
treatment, geography, industrial accidents,
or other scenarios offer the possibility to
study the effects ofhigher dose, sometimes
well-documented, exposures. For rarer can-
cers, case-control studies are often the
design ofchoice. There is still the need for
case-control studies that are population-
based, larger, and with better exposure assess-
ment methodology, although there have
been some advances in this respect in recent
years. New methods to obtain better occupa-
tional exposure data in community based
case-control studies have been developed
(14). The development, validation, and
application of biomarkers of exposure and
effect remain an active area ofresearch (15).
Where possible, studies should attempt to
more precisely define potential dose-
response relationships that will facilitate
causal evaluation and risk assessment.
Advances in molecular biology provided
the tools to investigate genetic susceptibility
both in terms ofsomatic alterations of the
tumor (e.g., p53 tumor-suppressor gene
mutations) and inherited alterations such as
metabolizing enzyme polymorphisms.
Epidemiologists should continue to attempt
to integrate these tools into field studies. As
another example, in some cases ofWilms
tumor, a childhood kidney tumor, and
retinoblastoma, a childhood eye tumor, the
abnormal allele was inherited from the father
(16,14. Epidemiologic studies could com-
bine methods to identify the parent oforigin
for the mutation with parental exposure data
to define more precisely the etiologic pathway
and critical windows ofexposure. The rapid
development ofmolecular biology, dissection
of the human genome, and databases will
provide invaluable resources for these efforts.
Animal studies should continue to investi-
gate specific mechanisms of cancer develop-
ment with special attention to timing and
windows ofexposure. These studies can pro-
vide invaluable information for our under-
standing of the development of human
cancers. Specific mechanisms such as epige-
netic events are ofgreat interest and animal
studies offer the possibility to test hypotheses,
particularly those related to the effects of
endogenous and exogenous exposures. The
ability to control the time window ofexpo-
sure and genetic background should yield
new information. These studies would be
improved ifthey were guided, in part, by the
findings from epidemiologic studies and
explored a greater range ofcompounds on the
basis ofmechanism.
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